Understanding the role that host membrane modification plays in coronavirus replication is essential for developing novel approaches to block the viruses that cause SARS and MERS.

New findings underscore the attractiveness of the HIV capsid – the structure that encloses the viral genome – as a therapeutic target.

New studies explain how T-cell receptors use force to recognize and protect us against pathogens.

New structural findings reveal how "gatekeeper" proteins participate in the secretion systems bacteria use to infect host cells.

Antibiotic-resistant bacteria can share resources to cause chronic infections, Vanderbilt investigators have discovered. The findings shed light on a long-standing question in infectious diseases and may inform new treatment strategies.

Compounds developed at Vanderbilt University may offer a new way to block influenza infection.

Understanding how the immune system responds to the respiratory virus HMPV is crucial for developing vaccines and anti-viral treatments.